We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
신규 편입 · 포트폴리오 비중 0.01%
신규 편입 · 포트폴리오 비중 0.04%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $17.25 · 16 analysts
Stored first · Google News · Yahoo Finance (English)
Should FMC’s (FMC) Dual-Mode Rimisoxafen Filing Reshape Its Crop Protection Innovation Narrative? - simplywall.st
Should FMC’s (FMC) Dual-Mode Rimisoxafen Filing Reshape Its Crop Protection Innovation Narrative? simplywall.st
This Dividend Stock Trading Near Multi-Year Lows Is a Risky Buy With Significant Upside Potential
FMC Corp. stock outperforms competitors on strong trading day - MarketWatch
FMC Corp. stock outperforms competitors on strong trading day MarketWatch
Senate passes 3 House concurrence bills, advances FMC Arugungu bill - Realnews Magazine
Senate passes 3 House concurrence bills, advances FMC Arugungu bill Realnews Magazine
FMC: Lowering target price to $9.00
Tessenderlo takes FMC stake - Speciality Chemicals Magazine
Tessenderlo takes FMC stake Speciality Chemicals Magazine
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 29. | After market close (AMC) | $0.21 | — | — | $894.38M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.12 | — | — | $791.4M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $2.85 | — | — | $3.02B | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $2.33 | — | — | $1.96B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 02. | Citigroup | — | Maintain | Neutral → Neutral | — | Citigroup: Neutral |
| 2026. 05. 02. | RBC Capital | — | Maintain | Sector Perform → Sector Perform | — | RBC Capital: Sector Perform |
| 2026. 05. 02. | JP Morgan | — | Maintain | Neutral → Neutral | — | JP Morgan: Neutral |
| 2026. 04. 24. | RBC Capital | — | Maintain | Sector Perform → Sector Perform | — | RBC Capital: Sector Perform |
| 2026. 04. 21. | Wells Fargo | — | Maintain | Equal-Weight → Equal-Weight | — | Wells Fargo: Equal-Weight |
| 2026. 04. 15. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 2,381,816 | $41.01M | 0.04% | — | New position |
| 2 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 1,732,601 | $24.03M | 0.04% | — | New position |
| 3 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 731,804 | $10.15M | 0.02% | — | New position |
| 4 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 414,228 | $7.13M | 0.01% | — | New position |